High schools have long been recognized for shaping students’ futures. According to a new study by researchers from Penn State, the University of Texas, the University of Wisconsin-Madison and the University of Minnesota, high schools […]
Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged in popularity for this purpose around the world.This article was originally published on MedicalXpress.com
The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published online April 8 in the Annals of Internal […]
Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury.This article was originally published on MedicalXpress.com
When it comes to managing weight loss and type 2 diabetes with medications, research shows that it’s out with the old and in with the new.This article was originally published on MedicalXpress.com
New research presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that the proportion of adolescents living with overweight or obesity in England has increased by 50% from 2008-2010 (22%) […]
Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years in adults with overweight or obesity who do not have diabetes, according to new research being presented at […]
Complications during pregnancy (or adverse pregnancy outcomes), like gestational diabetes and newly developed high blood pressure, act as nature’s stress test and may uncover an individual’s risk for heart disease later in life, according to […]
A new guideline to help health care providers manage obesity in children and adolescents takes a patient-centered approach, emphasizing behavioral and psychological supports that focus on outcomes valued by patients and their families.This article was […]
New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that around two-thirds of participants of the SURMOUNT-1 trial had only regained 5% or less of their […]
© 2025 SimplyWell.ca